BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5226510)

  • 1. Metabolic effects of allopurinol and allo-xanthine.
    Rundles RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):615-20. PubMed ID: 5226510
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol in patients with impaired renal function.
    Levin NW; Abrahams OL
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
    Kuzell WC; Seebach LM; Glover RP; Jackman AE
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):634-42. PubMed ID: 5335061
    [No Abstract]   [Full Text] [Related]  

  • 4. Allopurinol therapy of gout with renal complications.
    Sjöberg KH
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):688-90. PubMed ID: 5958699
    [No Abstract]   [Full Text] [Related]  

  • 5. Allopurinol in primary gout with and after the administration of uricosuric agents.
    Kersley GD
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):643-4. PubMed ID: 5958694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allopurinol in the treatment of gout and uric acid nephrolithiasis].
    Zöllner N; Schattenkirchner M
    Dtsch Med Wochenschr; 1967 Apr; 92(14):654-60. PubMed ID: 6024539
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of allopurinol and probenecid.
    Scott JT
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):623-6. PubMed ID: 5335059
    [No Abstract]   [Full Text] [Related]  

  • 10. Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
    Bartels EC
    JAMA; 1966 Nov; 198(7):708-12. PubMed ID: 5953324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allopurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Clin Ter; 1968 Apr; 45(2):141-54. PubMed ID: 5736585
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of gout.
    Lampe WT
    Pa Med; 1967 Jan; 70(1):52-3. PubMed ID: 6037719
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of gout with allopurinol. (Study of 106 cases)].
    Delbarre F; Auscher C; Amor B; de Géry A
    Sem Hop; 1967 Feb; 43(10):634-43. PubMed ID: 4292982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allpurinol in the treatment of hyperuricemia and chronic gout].
    Benedetti A; Nardini A; Busonera G
    Rev Clin Esp; 1969 Mar; 112(6):141-54. PubMed ID: 5347028
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of allopurinol on gouty and non-gouty uric acid nephropathy.
    Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):673-80. PubMed ID: 5958697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
    Rapado Errazti A
    Rev Esp Reum Enferm Osteoartic; 1966 Oct; 11(8):304-6. PubMed ID: 5997999
    [No Abstract]   [Full Text] [Related]  

  • 17. Microscopic studies on skeletal muscle in gout patients treated with allopurinol.
    Watts RW; Scott JT; Chalmers RA; Bitensky L; Chayen J
    Q J Med; 1971 Jan; 40(157):1-14. PubMed ID: 5090544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

  • 19. Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy.
    Krakoff IH; Balis ME
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):651-4. PubMed ID: 5958695
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects.
    Watts RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):657-9. PubMed ID: 5226512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.